Institute of Global Health Innovation, Imperial College London, London, W2 1NY, United Kingdom.
Institute of Global Health Innovation, Imperial College London, London, W2 1NY, United Kingdom.
EBioMedicine. 2023 Jul;93:104685. doi: 10.1016/j.ebiom.2023.104685. Epub 2023 Jun 27.
The increasing use of mobile messaging within healthcare, poses challenges for screening programmes, which involve communicating with large, diverse populations. This modified Delphi study aimed to create guidance regarding the use of mobile messaging for screening programmes, to facilitate greater, and equitable screening uptake.
Initial recommendations were derived from a literature review, expert scoping questionnaire, public consultation, and discussion with relevant national organisations. Experts from the fields of public health, screening commissioning, industry and academia voted upon the importance and feasibility of these recommendations across two consensus rounds, using a 5-point Likert scale. Items reaching consensus, defined a priori at 70%, on importance and feasibility formed 'core' recommendations. Those reaching this threshold on importance only, were labelled 'desirable'. All items were subsequently discussed at an expert meeting to confirm suitability.
Of the initial 101 items, 23 reached consensus regarding importance and feasibility. These 'core' items were divided across six domains: message content, timing, delivery, evaluation, security, and research considerations. 'Core' items such as explicitly specifying the sender and the role of patient involvement in development of screening message research had the highest agreement. A further 17 'desirable' items reached consensus regarding importance, but not feasibility, including the integration into GP services to enable telephone verification.
These findings forming national guidance for services, will enable programmes to overcome implementation challenges and facilitate uptake of screening invitations. By providing a list of desirable items, this study provides areas for future consideration, as technological innovation in messaging continues to grow.
NIHR Imperial Patient Safety Translational Research Centre.
移动信息在医疗保健中的使用日益增多，给涉及与大量不同人群进行沟通的筛查项目带来了挑战。本改良德尔菲研究旨在制定有关使用移动信息进行筛查项目的指南，以促进更大、更公平的筛查参与度。
最初的建议源自文献回顾、专家范围界定问卷调查、公众咨询以及与相关国家组织的讨论。公共卫生、筛查委托、行业和学术界的专家使用 5 点李克特量表，在两轮共识投票中对这些建议的重要性和可行性进行投票。在重要性和可行性上达到事先设定的 70%共识的项目构成了“核心”建议。仅在重要性上达到这一阈值的项目被标记为“可取”。所有项目随后在专家会议上进行讨论，以确认其适用性。
最初的 101 项中有 23 项在重要性和可行性方面达成了共识。这些“核心”项目分为六个领域：信息内容、时间安排、传递、评估、安全性和研究考虑。明确指定发件人和患者在筛查信息研究开发中的角色等“核心”项目得到了最高的共识。还有 17 项“可取”项目在重要性上达成了共识，但在可行性上没有达成共识，包括纳入全科医生服务以实现电话验证。
这些发现为服务制定了国家指南，将使项目能够克服实施挑战，促进筛查邀请的参与度。通过提供一系列可取的项目，本研究为未来的考虑提供了领域，因为信息传递方面的技术创新不断发展。
NIHR 帝国患者安全转化研究中心。
